Survival of stage IV breast cancer patients improves with stem cell treatment, study finds
Monday, July 25, 2011 - 08:30
in Health & Medicine
(Medical Xpress) -- A new long-term study of women with Stage IV breast cancer at the Stanford University School of Medicine is likely to revive a decade-old debate about high-dose chemotherapy as a treatment option. Specifically, researchers found that a greater proportion of patients who received the aggressive treatment 12 to 14 years ago, followed by a rescue with their own, specially purified blood stem cells that had been purged of cancer, survived compared with those who were rescued with unmanipulated blood grafts.